A. Mathieu-Boué
Impact in
- Oncology top 5%
- Viral-associated cancers and disorders
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
- Polyomavirus and related diseases
- Pancreatic and Hepatic Oncology Research
- Toxicology top 5%
Papers in
-
- Cancer therapeutics and mechanisms 7
- Oncology 7
- Lung Cancer Research Studies 2
- Viral-associated cancers and disorders 2
- Neutropenia and Cancer Infections 2
- Co-authors
- Alain Gouyette (3 shared papers)G. Catimel (2 shared papers)R. Bugat (3 shared papers)Peter J. Houghton (1 shared paper)Janet A. Houghton (1 shared paper)Pamela J. Cheshire (1 shared paper)G G Chabot (2 shared papers)P Siegenthaler (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Annals of Oncology (3 papers)Clinical Cancer Research (1 paper)European Journal of Cancer (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- FranceNetherlandsSwitzerland
In The Last Decade
A. Mathieu-Boué
14 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 58
- Oncology 675
- Toxicology 34
- Pathology and Forensic Medicine 162
- Molecular Biology 447
- Transplantation 16
Countries citing papers authored by A. Mathieu-Boué
This map shows the geographic impact of A. Mathieu-Boué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Mathieu-Boué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Mathieu-Boué more than expected).
Fields of papers citing papers by A. Mathieu-Boué
This network shows the impact of papers produced by A. Mathieu-Boué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Mathieu-Boué. The network helps show where A. Mathieu-Boué may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Mathieu-Boué, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 285 | |
| 2 | 1995 | 148 | |
| 3 | Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin. | 1993 | 148 |
| 4 | Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients. | 1994 | 134 |
| 5 | 2010 | 99 | |
| 6 | 1996 | 98 | |
| 7 | 1995 | 94 | |
| 8 | 1992 | 71 | |
| 9 | 2007 | 9 | |
| 10 | 2007 | 8 | |
| 11 | 1995 | 5 | |
| 12 | 1998 | 4 | |
| 13 | 2011 | 2 | |
| 14 | 2006 | 1 |
About A. Mathieu-Boué
A. Mathieu-Boué is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Organic Chemistry and Gastroenterology, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Sarcoma Diagnosis and Treatment (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Lung Cancer Research Studies (2 papers), Viral-associated cancers and disorders (2 papers), Neutropenia and Cancer Infections (2 papers), Bioactive Compounds and Antitumor Agents (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (675 citations), Toxicology (34 citations), Pathology and Forensic Medicine (162 citations), Molecular Biology (447 citations) and Transplantation (16 citations). A. Mathieu-Boué has collaborated with scholars based in France, Netherlands and Switzerland. Frequent co-authors include Alain Gouyette, G. Catimel, R. Bugat, Peter J. Houghton, Janet A. Houghton, Pamela J. Cheshire, G G Chabot, P Siegenthaler, Luc Dirix and Miranda Buitenhuis. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, European Journal of Cancer and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.